These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13505825)

  • 21. The inhibition of cholinesterases by alkyl-phosphates and alkylphenolphosphates.
    BURGEN AS; HOBBIGER F
    Br J Pharmacol Chemother; 1951 Dec; 6(4):593-605. PubMed ID: 14904884
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholesterol content of spinal cord and sciatic nerve of hens after organophosphate and carbamate administration.
    Williams CH; Johnson HJ; Casterline JL
    J Neurochem; 1966 Jun; 13(6):471-4. PubMed ID: 5914241
    [No Abstract]   [Full Text] [Related]  

  • 23. The reactivation of cholinesterase after Inhibition in vivo by some dimethyl phosphate esters.
    VANDEKAR M; HEATH DF
    Biochem J; 1957 Oct; 67(2):202-8. PubMed ID: 13471533
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of cholinesterase with methylfluorophosphorylcholine and carbocholine: spontaneous return of activity.
    FREDRIKSSON T; TIBBLING G
    Biochem Pharmacol; 1960 Jun; 3():184-9. PubMed ID: 13824696
    [No Abstract]   [Full Text] [Related]  

  • 25. Cholinesterase-inhibiting properties of two vinyl-substituted phosphates.
    MORSE MS; KODAMA JK; HINE CH
    Proc Soc Exp Biol Med; 1953; 83(4):765-8. PubMed ID: 13120880
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholinesterase inhibition at the myoneural junction.
    DENZ FA
    Br J Exp Pathol; 1954 Oct; 35(5):459-71. PubMed ID: 13208935
    [No Abstract]   [Full Text] [Related]  

  • 27. [The mechanism of the transport of organophosphorus compounds across the histo-hematic barriers].
    Miroshkina VN; Kosmachev AB; Salova LS
    Eksp Klin Farmakol; 1999; 62(6):48-51. PubMed ID: 10650528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorpromazine as an inhibitor of brain cholinesterases.
    JOHANNESSON T; LAUSEN HH
    Acta Pharmacol Toxicol (Copenh); 1961; 18():398-406. PubMed ID: 14451934
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of some anticholinesterase substances on the monoamine oxidase of the brain].
    VINCENT D; SEGONZAC G; MARQUES-VINCENT MC
    C R Seances Soc Biol Fil; 1961; 155():2446-8. PubMed ID: 13926068
    [No Abstract]   [Full Text] [Related]  

  • 30. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate.
    Carrington CD; Abou-Donia MB
    J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of organophosphorus cholinesterase inhibitors.
    HOLMSTEDT B
    Pharmacol Rev; 1959 Sep; 11():567-688. PubMed ID: 14402820
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
    Jokanović M
    Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinesterase activity and electroencephalograms during circling induced by the intracarotid injection of di-isopropyl fluorophosphate (DFP).
    HARWOOD CT
    Am J Physiol; 1954 May; 177(2):171-4. PubMed ID: 13158541
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of repeated exposures of GB vapor on erythrocyte and brain cholinesterases in rats.
    COHEN BS; OBERST FW; CROOK JW; HARRIS C
    J Pharmacol Exp Ther; 1956 Feb; 116(2):209-15. PubMed ID: 13296035
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemical structure and biological activity of organic phosphate cholinesterase inhibitors].
    VOLKOVA RI; GODOVIKOV NN; KABACHNIK MI; MAGAZANIK LG; MASTRIUKOVA TA; MIKHEL'SON MIa; ROZHKOVA EK; FRUENTOV NK; IAKOVLEV VA
    Vopr Med Khim; 1961; 7():250-9. PubMed ID: 13782007
    [No Abstract]   [Full Text] [Related]  

  • 36. Retention of inhaled sarin vapor and its effect on red blood cell cholinesterase activity in man.
    Oberst FW; Koon WS; Christensen MK; Crook JW; Cresthull P; Freeman G
    Clin Pharmacol Ther; 1968; 9(4):421-7. PubMed ID: 5655475
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanism of inhibition of cholinesterases by organophosphorus compounds.
    ALDRIDGE WN; DAVISON AN
    Biochem J; 1953 Dec; 55(5):763-6. PubMed ID: 13115369
    [No Abstract]   [Full Text] [Related]  

  • 38. [Qualitative studies on the inhibition of the cholinesterase in erythrocytes by prostigmine and choline].
    MAIER EH; BAMMER HG
    Biochem Z; 1951 Oct; 322(2):85-105. PubMed ID: 14934691
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of dichlorvos (DDVP) on mouse liver glutathione levels and lack of potentiation by methyl iodide and TOTP.
    Ehrich M; Cohen SD
    Biochem Pharmacol; 1977 May; 26(10):997-1000. PubMed ID: 861048
    [No Abstract]   [Full Text] [Related]  

  • 40. The neurotoxicity and anticholinesterase properties of some substituted phenyl phosphates.
    HINE CH; DUNLAP MK; RICE EG; COURSEY MM; GROSS RM; ANDERSON HH
    J Pharmacol Exp Ther; 1956 Feb; 116(2):227-36. PubMed ID: 13296038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.